Geistlich

📍 Root Längenbold, Switzerland👥 472 employees💰 Last funded May 2026
Pharmaceutical Manufacturing🌐 geistlich.com
Website LinkedIn
Geistlich is a global leader dedicated to advancing regenerative medicine. Geistlich has been the world market leader in the field of regenerative dentistry for many years. In addition, Geistlich is committed to providing comprehensive support to clinicians in the field of regenerative medicine through scientific research, innovative developments as well as educational programs. Geistlich is a Swiss family-owned company with tradition since 1851. With 15 subsidiaries and 60 distributors, the company reaches around 90 markets and employs over 800 people. The ownership structure enables the company to plan long-term and to consistently develop innovative products. Geistlich Pharma AG continuously invests in developing its research and technology and relies on its qualified and specialized employees. Currently Geistlich Pharma is - the global market leader in regenerative dentistry - the leader in biological bone and cartilage regeneration - supplies drugs and medical devices in selected application areas
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Geistlich?
Geistlich has 1 investor on record on gritt.io.
When did Geistlich last raise funding?
The most recent investment in Geistlich recorded on gritt.io was in May 2026.
What industry is Geistlich in?
Geistlich operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Geistlich based?
Geistlich is headquartered in Root Längenbold, Switzerland.